Tyrosine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Serine-Threonine Kinase Inhibitors Threonine-Tyrosine Kinase Inhibitors | Urothelial Cancer | Non Small Cell Lung Cancer | Bladder Cancer | Neuroendocrine Tumor | Colorectal Cancer | Solid Tumor | Small Cell Lung Cancer | Melanoma | Lung Cancer | HER2 Positive Breast Cancer | Non-Hodgkin’s Lymphoma |
---|---|---|---|---|---|---|---|---|---|---|---|
atezolizumab | |||||||||||
trametinib | |||||||||||
nivolumab | |||||||||||
pembrolizumab | |||||||||||
everolimus | |||||||||||
durvalumab + tremelimumab | |||||||||||
trastuzumab | |||||||||||
Immunotherapy | |||||||||||
L/P-VIPD |